Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06026943 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Alpha Radiation Emitters for the Treatment of Pancreatic Cancer for the Treatment of Locally Advanced Pancreatic Cancer

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date changed from estimate of Dec 4, 2025 to May 6, 2026
    • Study title shortened, about 2 words
    v6
  2. Trial status: Not Yet Recruiting to Recruiting
    • Primary completion date: Jan 2026 to Jan 2027
    • Start date: Jan 2025 to Dec 4, 2025
    • Study sites: 0 to 1
    v5
  3. Start date: Oct 2024 to Jan 2025v4
  4. Start date: Sep 2024 to Oct 2024v3
  5. Start date: Jan 2024 to Sep 2024v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for advanced pancreatic cancer
Trial Details
NCT Number NCT06026943
Lead Sponsor Alpha Tau Medical LTD.
Conditions
(from sponsor)		 Pancreatic Cancer, Unresectable Pancreatic Cancer, Pancreatic Adenocarcinoma
Related terms Pancreatic Neoplasms
Enrollment 15 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov